EpiRegen Therapeutics Completes $60 Million Series B Financing to Advance CRISPR-Based Epigenetic Therapies

Recently, Epigenic Therapeutics, Inc. announced the successful completion of a $60 million Series B financing round. The financing was led by Lapam Capital, with previous investors Qiming Venture Partners and Orbimed continuing to participate. Additionally, GZYY Capital and several other well-known industry investment institutions joined in.

Epigenic is a leading biotechnology company dedicated to developing next-generation epigenetic regulation technologies for the treatment of chronic diseases. Compared with the traditional gene editing tools that cut DNA, Epigenic's unique EPIREG™ technology offers a completely different solution. Through precise DNA methylation and histone modification, EPIREG™ can efficiently and durably silence target genes, providing revolutionary innovative treatment options for patients with chronic diseases. It is worth mentioning that this solution will effectively address safety concerns brought by traditional gene editing.

Epigenic's patented technology platform continuously explores for better CRISPR-Cas components through its developed artificial intelligence (AI) algorithms, regulating target gene expression or simultaneously manipulating the expression of multiple genes without altering the DNA sequence. Among similar technologies, the EPIREG™ technology platform does not require DNA cutting, thus avoiding potential risks such as off-target effects, short half-life, and poor patient compliance. Combined with the company's proprietary patented lipid nanoparticle (LNP) drug delivery system, the company’s technology platform has shown applications in metabolism, cardiovascular,Viral Hepatitis, and has been validated in in vivo and in vitro models of ophthalmology and rare diseases, enabling precise and effective delivery of drugs to target cells and tissues.

In order to allow everyone to better learn and communicate with each other, the media platform"WeChat Official Account 'Cell Gene Therapy' Team"A WeChat group for cell therapy and gene therapy has been established. Interested friends can scan the QR code below to add the editor's WeChat and join the cell therapy and gene therapy discussion group.。